Showing 801 - 820 of 975 results
Webinar: Strengthening the future of the nuclear workforce
Join us for this online webinar to explore and discuss the huge opportunities in growing a dynamic and impactful future nuclear workforce.
Research reveals how disordered proteins contribute to the properties of the rabies virus
A large team of international researchers have used synchrotron techniques to understand how key proteins contribute to the virulence of the rabies virus, sometimes called the “zombie virus.”
Award recipients to present Distinguished Lectures
Award recipients Dr Richard Garrett and Dr Nigel Lengkeek with Dr Tien Pham will deliver a Distinguished Lecture on 15 November at ANSTO.
Significant progress on breakthrough cancer therapy
Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.
Gentech Generator
Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.
Teachers Down Under Head to CERN: Australian Educators Selected for International High School Teacher Program
Part of the Large Hardon Collider
Senior Scientist - X-ray Fluorescence Microscopy
Role at ANSTO
Development of radioisotopes
Research and development activity explores new, boutique radioisotopes, including positron, gamma and beta/gamma emitter. The aim is to provide material for the next generation of diagnostic and therapeutic radiopharmaceuticals
Critical minerals projects funded under Australian Research Centre Projects Program
ANSTO is contributing to key critical minerals projects funded by the Federal Government.
Cross collaboration on highly competitive funding for projects and facilities
Building knowledge of changes in uranium chemistry
A new systematic investigation of the origins of atomic structural distortions in compounds containing uranium has relevance for spent nuclear fuel .
Board member
Dr Storr has worked for over 40 years in nuclear science and technology in a range of positions spanning operations, research and executive management.
Principal Scientist – X-ray Fluorescence Microscopy
Principal Scientist – X-ray Fluorescence Microscopy
Instrument Scientist
Role at ANSTO
Dr Richard Mole is an instrument scientist co-responsible for the cold-neutron time-of-flight spectrometer PELICAN.
Mitigation and Optimisation of Radiation Responses
This program explores the mechanism and outcome of the interaction of radiation on biological systems in order to improve our understanding of the impact of radiation on the brain, optimise radiotherapy and develop mitigation strategies for space travellers.
2022 Shorebirds Competition Summary and Results
Shorebirds Competition 2022 results.
Radiotracer studies
The use of radioisotopes, radiolabeled molecules and radioactive particles in conjunction with a range of quantitative imaging spectroscopy and radiation counting methods.
ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
OPAL reactor back online after planned long shutdown
ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.